Skip to main content
. 2022 Apr 5;7(15):12467–12473. doi: 10.1021/acsomega.2c00638

Figure 3.

Figure 3

(A) An illustration of the structure of SARS-CoV-2 (left) and its cross-section (right). An illustration of (B) the interaction of the spike protein receptor-binding domain with ACE2 and of (C) neutralizing antibodies developed in response to being exposed to the virus (created using Biorender).